Drug Safety

2001 - 2025

Current editor(s): Nitin Joshi

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 38, issue 7, 2015

DNA Barcoding and Pharmacovigilance of Herbal Medicines pp. 611-620

Hugo J. Boer, Mihael C. Ichim and Steven G. Newmaster

Volume 37, issue 10, 2014

Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum pp. 743-759

Jürgen Beckmann, Ulrich Hagemann, Priya Bahri, Andrew Bate, Ian Boyd, Gerald Dal Pan, Brian Edwards, I. Edwards, Kenneth Hartigan-Go, Marie Lindquist, John McEwen, Yola Moride, Sten Olsson, Shanthi Pal, Rachida Soulaymani-Bencheikh, Marco Tuccori, Claudia Vaca and Ian Wong

Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet pp. 761-764

G. Norén

Pharmacovigilance in China: Current Situation, Successes and Challenges pp. 765-770

Li Zhang, Lisa Wong, Ying He and Ian Wong

Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies pp. 771-776

Joshua Gagne

Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art pp. 777-790

Rave Harpaz, Alison Callahan, Suzanne Tamang, Yen Low, David Odgers, Sam Finlayson, Kenneth Jung, Paea LePendu and Nigam Shah

The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis pp. 791-804

Jacqueline Flank, Lillian Sung, Christopher Dvorak, Wendy Spettigue and L. Dupuis

Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK pp. 805-813

Pernille Warrer, Lise Aagaard and Ebba Hansen

Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events pp. 815-829

Agata Ptaszynska, Kristina Johnsson, Shamik Parikh, Tjerk Bruin, Anne Apanovitch and James List

Volume 35, issue 9, 2012

Early Investigation of QTc Liability pp. 695-709

Rashmi R. Shah and Joel Morganroth

A Pathway to Improved Prospective Observational Post-Authorization Safety Studies pp. 711-724

Victor A. Kiri

A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization pp. 725-731

Andrew J. Muzyk, Sarah K. Rivelli, Wei Jiang, Heather Heinz, Amber Rayfield and Jane P. Gagliardi

Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records pp. 733-743

Andrew Tomlin, David Reith, Susan Dovey and Murray Tilyard

Drug Interactions in Dying Patients pp. 745-758

Sebastian Frechen, Anna Zoeller, Klaus Ruberg, Raymond Voltz and Jan Gaertner

Drug Fever pp. 759-767

Dominique Vodovar, Christine LeBeller, Bruno Mégarbane, Agnes Lillo-Le-Louet and Thomas Hanslik

Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments pp. 769-781

Chen Wu, Chaim M. Bell and Walter P. Wodchis

Volume 24, issue 14, 2001

Technologies to Improve Immunisation Safety pp. 1019-1026

C. John Clements, Maria Teresa Aguado and Luis Jódar

Benefits and Risks of Self Medication pp. 1027-1037

Carmel M. Hughes, James C. McElnay and Glenda F. Fleming

Comparative Tolerability of First-Generation Selective Estrogen Receptor Modulators in Breast Cancer Treatment and Prevention pp. 1039-1053

Michèle G. Curtis

Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy pp. 1055-1063

Miriam B. Borden and Ann L. Parke

Asthma Medications and their Potential Adverse Effects in the Elderly pp. 1065-1080

Donald Mackenzie Newnham

Adverse Drug Reactions Related to the Use of NSAIDs with a Focus on Nimesulide pp. 1081-1090

Anita Conforti, Roberto Leone, Ugo Moretti, Federico Mozzo and Giampaolo Velo